Calgary clinic to help families grow with new, affordable approach to IVF
CALGARY, June 29, 2017 /CNW/ - Effortless IVF Canada, an organization focused on broadening the delivery of fertility medicine in Canada, this week received both Laboratory and Clinical Accreditation for its Calgary location from the College of Physicians and Surgeons of Alberta. This was the final step in the nearly yearlong build and approval process and now patients, currently awaiting care, can begin treatment cycles.
"We are excited to be over this final milestone and begin treatment with our patients who have gone through the intake process," says Dr. Lyle Oberg, President, Effortless IVF Canada. "We really appreciate all the support of our Effortless IVF community — our patients and team at the clinic."
In Effortless IVF Canada's alternate approach, fertilization and early embryonic development takes place inside a women's own body utilizing a Health Canada market authorized medical device known as INVOcell™. This eliminates the need for expensive lab work, incubators and monitoring personnel. It also allows for fewer ultrasounds, appointments and less medication with a recent clinical trial demonstrating nearly identical live birth rates to IVF (60% IVF, 55% INVO™). Effortless IVF Canada is offering families who suffer from infertility the opportunity to pursue parenthood in a manner less intrusive to their finances and lifestyle.
Effortless IVF Canada is pioneering the commercialization of INVO™ treatments using INVOcell™, with plans for up to nine more clinics across the country. As fertility options continue to evolve, Effortless IVF Canada aims to empower those battling infertility to take charge of their healthcare and pursue this innovative, cost-conscious and equally effective route to parenthood.
New patients can book without a referral now to see our intake Physician https://www.effortlessivf.ca/order/calgary.
About Effortless IVF Canada
Effortless IVF is a North American group of companies focused on broadening the delivery of fertility medicine by adopting innovative technologies and implementing them within an efficient and proactive service model that meets our goal of Fertility for Everybody. For more information, please visit www.effortlessivf.ca.
About INVO Bioscience
INVO Bioscience (IVOB: OTC US) is a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our solution, the INVO Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care. For more information please visit http://invobioscience.com/.
INVOcell is a trademark of INVO Bioscience
SOURCE Effortless IVF Canada
For further information: To request media interviews, please contact: Kendra Penrose at firstname.lastname@example.org